Medtronic plc, a global leader in healthcare technology, today announced that Linnea Burman will succeed Dan Volz as SVP & president, Neurovascular business, part of the Neuroscience portfolio. In her new capacity, Burman will be responsible for portfolio strategy, product development, commercial execution and the overall financial performance of the Medtronic global business focused on stroke treatment. Burman will report to Brett Wall, EVP & president, Neuroscience Portfolio. Dan Volz [...]

This is an abstract of the document. To keep reading, click here and get access to the original version.

Attachments

  • Original Link
  • Permalink

Disclaimer

Medtronic plc published this content on 28 May 2024 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 28 May 2024 13:45:01 UTC.